Abstract
Chemoresistance is the most common cause of chemotherapy failure during breast cancer (BCA) treatment. It is generally known that the mechanisms of chemoresistance in tumors involve multiple genes and multiple signaling pathways,; if appropriate drugs are used to regulate the mechanisms at the gene level, it should be possible to effectively reverse chemoresistance in BCA cells. It has been confirmed that chemoresistance in BCA cells could be reversed by ginsenoside Rh2 (G-Rh2). Preliminary studies of our group identified some drug- resistance specific miRNA. Accordingly, we proposed that G-Rh2 could mediate drug-resistance specific miRNA and corresponding target genes through the gene regulatory network; this could cut off the drug-resistance process in tumors and enhance treatment effects. G-Rh2 and breast cancer cells were used in our study. Through pharmaceutical interventions, we could explore how G-Rh2 could inhibit chemotherapy resistance in BCA, and analyze its impact on related miRNA and target genes. Finally, we will reveal the anti-resistance molecular mechanisms of G-Rh2 from a different angle in miRNA-mediated chemoresistance signals among cells.
References
Nov 17, 2010·Journal of Cellular Biochemistry·Sunga ChoiSoo-Jin Kim
Mar 5, 2011·Acta Pharmacologica Sinica·Nan WuHua Feng
May 28, 2011·British Journal of Pharmacology·Jingwei ZhangGuangji Wang
Sep 29, 2011·Clinical Epigenetics·Kristy R KutanziIgor P Pogribny
Jan 21, 2012·Trends in Cell Biology·Xi ChenChen-Yu Zhang
Jun 30, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jingwei ZhangGuangji Wang
Oct 23, 2012·Archives of Medical Research·Xiu-juan LiJin-hai Tang
Nov 16, 2012·Oncology Reports·In-Sook AnSeunghee Bae
Mar 29, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Qian-Qian DengJin Xiang
May 22, 2013·Biochemical Pharmacology·L S ChanRicky N S Wong
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Yang-Chen LiuXin-En Huang
Aug 16, 2013·The Journal of Molecular Diagnostics : JMD·Nadine RatertKlaus Jung
Nov 13, 2013·Cellular Signalling·Shin HamadaTooru Shimosegawa
Jan 10, 2014·Oncology Reports·Han-Han ZhangShu-Yang Xie
Jan 22, 2014·FEBS Letters·Samik ChakrabortyTanya Das
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Jian-Ping GongDong-Feng Wang
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Lin WangJie Cao
Citations
May 15, 2016·Acta Biochimica Et Biophysica Sinica·Jingjia HuangZhiyong Luo
Nov 6, 2018·Journal of Asian Natural Products Research·Wei-Wen ChenYing-Zi Zhuang
Jan 14, 2018·Scientific Reports·Hadi Zare-ZardiniAbdol-Khalegh Bordbar
Dec 6, 2019·The American Journal of Chinese Medicine·Fu PengCheng Peng
Oct 28, 2019·Current Topics in Medicinal Chemistry·Yu-Hang GuoYing Gao
Sep 11, 2018·Oncology Letters·Weiwen ChenYurong Qiu
Apr 2, 2016·International Journal of Molecular Medicine·Ying-Jie YiShu-Yang Xie
Oct 2, 2020·Drug Delivery·Xiaojing XiaZhiying Zhao
Aug 26, 2020·Archives of Pharmacal Research·Yujin JinKyung-Sun Heo
Jun 4, 2018·Chinese Journal of Integrative Medicine·Huan-Dong ZhaoYu-Xiang Chen
Jul 30, 2015·Briefings in Bioinformatics·Jung Hun Oh, Joseph O Deasy
Mar 6, 2019·Drug Delivery·Xiao QueMingfeng Qiu
Oct 2, 2020·Phytotherapy Research : PTR·Heng ZouZhongliang Ma